Soru

Zorluk: ZorBipolar and Related Disorders

A 4242-year-old male construction manager presents to the clinic accompanied by his wife. He reports a 66-week history of feeling "completely hollow," sleeping up to 1414 hours a day, having a ravenous appetite, and experiencing severe heavy feelings in his arms and legs. He has gained 77 kg (15.415.4 lbs) during this period. Review of his medical history reveals an incident four years ago where he went 88 days sleeping only 22 hours a night, became convinced he was chosen by a deity to build a new city, and spent 40,00040,000 dollars of his savings on barren land. This episode resulted in an involuntary psychiatric hospitalization. He stopped taking all prescribed medications three years ago. His vital signs are normal, and a recent comprehensive metabolic panel and thyroid-stimulating hormone (TSH) level of 2.22.2 μ\mu U/mL (normal: 0.40.4-4.04.0 μ\mu U/mL) are unremarkable. Which of the following is the most appropriate next step in pharmacotherapy for this patient's current presentation?

  1. A
    Initiate citalopram
  2. B
    Initiate levothyroxine
  3. Initiate quetiapineCevap
  4. D
    Initiate venlafaxine
  5. E
    Initiate haloperidol

Cevap

Initiate quetiapine
This patient is currently experiencing a major depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis). However, his history of a distinct period of abnormally elevated mood, decreased need for sleep, grandiosity, and hospitalization confirms a diagnosis of Bipolar I disorder. Therefore, his current presentation is acute bipolar depression. First-line pharmacotherapy for bipolar depression includes specific second-generation antipsychotics (such as quetiapine, lurasidone, or cariprazine) or mood stabilizers (such as lithium or lamotrigine). Quetiapine is a well-established, FDA-approved monotherapy for acute bipolar depression and is the most appropriate next step in management.

Adım Adım Çözüm

1
Identify the patient's current clinical syndrome.
The patient is experiencing a major depressive episode characterized by depressed mood, hypersomnia, hyperphagia, and leaden paralysis (atypical features).
Establishing the current phase of the illness is required to guide symptom-specific management.
2
Evaluate the patient's psychiatric history for prior mood episodes.
The patient has a history of an episode lasting 8 days with decreased need for sleep, grandiosity, and significant impairment requiring hospitalization.
A history of a manic episode changes the diagnosis from Major Depressive Disorder to Bipolar I Disorder.
3
Select the appropriate pharmacotherapy for acute Bipolar I depression.
Quetiapine is selected over antidepressant monotherapy.
Quetiapine is an approved and effective treatment for bipolar depression, whereas SSRI/SNRI monotherapy is contraindicated due to the risk of inducing mania.

Anahtar Kavram

Patients with bipolar depression must be treated with appropriate mood stabilizers or specific second-generation antipsychotics (e.g., quetiapine, lurasidone) rather than antidepressant monotherapy to avoid precipitating a manic switch.
Bu soruyu puanla